Related Experiment Video
Updated: Aug 7, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Remodeling in asthma and chronic obstructive pulmonary disease
1Department of Pulmonology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9731 GZ Groningen, The Netherlands. d.s.postma@int.umcg.nl
Proceedings of the American Thoracic Society
|June 27, 2006
Summary
Resident cells drive airway remodeling and fibrosis in asthma and COPD. The study explores the roles of vasculature, vascular endothelial growth factor, and extracellular matrix turnover in lung function loss.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pathology
Background:
- Airway remodeling and fibrosis are key to lung function loss in asthma and COPD.
- Inflammatory cells have been the focus, but resident cells also contribute significantly.
- New research highlights the role of resident cells in tissue pathology.
Purpose of the Study:
- To discuss new aspects of airway remodeling and fibrosis in asthma and COPD.
- To investigate the role of vasculature and vascular endothelial growth factor (VEGF).
- To analyze extracellular matrix (ECM) turnover and its regulation.
Main Methods:
- Review of current literature on airway remodeling and fibrosis.
- Discussion of the role of resident cells, vasculature, and VEGF.
- Analysis of ECM components and their alterations.
- Exploration of transforming growth factor (TGF) and Smad signaling pathways.
Main Results:
- Resident cells, vasculature, and VEGF contribute to airway obstruction and fibrosis.
- Alterations in lung ECM components (collagen, elastic fibers, proteoglycans) are evident in asthma and COPD.
- Transforming growth factor (TGF) and Smad signaling are involved in ECM turnover.
Conclusions:
- ECM damage and repair processes contribute to airway and lung tissue pathology.
- Vasculature may exacerbate ECM damage and repair, enhancing disease progression.
- The specific localization of pathology depends on disease etiology (allergen vs. smoke) and local environment.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation